Outlook Therapeutics, Inc.
OTLK· Nasdaq
OTLKOutlook Therapeutics, Inc.
Filed Aug 15, 2016 · 10-Q · 46 days after period end · 0001571049-16-017518
| Metric | Q3 2016 | Q3 2015 |
|---|---|---|
| Revenue | $494.89K | $1.29M |
| Net Income | -$22.33M | -$11.34M |
| EPS Diluted | -$1.60 | -$1.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Outlook Therapeutics, Inc. · CIK 1649989 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 15, 2016 · 46 d after period end
